Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000236667

Medchemexpress LLC TL13-112 | 2229037-19-6 | MFCD12922943 | 98.0% | 1002.57 | C49H60ClN9O10S | 10MM 1ML
SDP

Catalog No. 5000236667
Encompass_Preferred

TL13-112 is a proteolysis targeting chimera (PROTAC) designed to selectively induce degradation of anaplastic lymphoma kinase (ALK) in cellular models. It is supplied as a solid and as a 10 mM solution in DMSO for use in preclinical degradation studies, mechanistic assays, and target validation workflows.

  • Selective ALK degradation in cellular assays.
  • High purity suitable for biological studies.
  • Available as solid or 10 mM DMSO solution for convenient dosing.
  • Recommended storage conditions for powder and solvent preparations.
  • Applicable to mechanistic studies and preclinical target validation.

Catalog No. 50-002-36667 Supplier Medchemexpress LLC Supplier No. HY12391910MM 1ML
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

TL13-112 is a proteolysis targeting chimera (PROTAC) designed to selectively induce degradation of anaplastic lymphoma kinase (ALK) in cellular models. It is supplied as a solid and as a 10 mM solution in DMSO for use in preclinical degradation studies, mechanistic assays, and target validation workflows.

  • Selective ALK degradation in cellular assays.
  • High purity suitable for biological studies.
  • Available as solid or 10 mM DMSO solution for convenient dosing.
  • Recommended storage conditions for powder and solvent preparations.
  • Applicable to mechanistic studies and preclinical target validation.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.